Manon E. Wildenberg

15.2k total citations · 2 hit papers
103 papers, 5.1k citations indexed

About

Manon E. Wildenberg is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Manon E. Wildenberg has authored 103 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 36 papers in Surgery and 35 papers in Genetics. Recurrent topics in Manon E. Wildenberg's work include Inflammatory Bowel Disease (29 papers), Microscopic Colitis (12 papers) and Immune Cell Function and Interaction (11 papers). Manon E. Wildenberg is often cited by papers focused on Inflammatory Bowel Disease (29 papers), Microscopic Colitis (12 papers) and Immune Cell Function and Interaction (11 papers). Manon E. Wildenberg collaborates with scholars based in Netherlands, United States and United Kingdom. Manon E. Wildenberg's co-authors include Gijs R. van den Brink, Daniël W. Hommes, Geert D’Haens, Anne Christine W. Vos, Marjolijn Duijvestein, Auke P. Verhaar, Alon D. Levin, Leonie M. van Duivenvoorde, René E. M. Toes and Cornelis J.M. Melief and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Manon E. Wildenberg

100 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

2001 834 citations Manon E. Wildenberg et al. profile →
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

2015 304 citations Gijs R. van den Brink, Manon E. Wildenberg et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manon E. Wildenberg Netherlands	31	2.1k	1.5k	1.1k	1.1k	952	103	5.1k
Michel Peuchmaur France	49	1.9k 0.9×	1.3k 0.8×	2.0k 1.8×	1.5k 1.4×	1.1k 1.2×	189	7.6k
Stefania Vetrano Italy	33	1.2k 0.6×	1.1k 0.8×	1.1k 1.0×	788 0.7×	636 0.7×	82	3.8k
Philippe Saas France	43	3.4k 1.6×	469 0.3×	1.8k 1.6×	1.3k 1.2×	877 0.9×	210	7.0k
Manuela Battaglia Italy	39	5.2k 2.5×	1.8k 1.2×	1.2k 1.0×	1.1k 1.0×	488 0.5×	110	7.8k
Ryuichi Okamoto Japan	39	1.4k 0.7×	1.3k 0.9×	1.8k 1.6×	1.5k 1.4×	490 0.5×	171	5.0k
Frédéric Rieux‐Laucat France	42	4.9k 2.3×	1.4k 1.0×	2.8k 2.5×	1.2k 1.1×	639 0.7×	124	7.7k
José L. Cohen France	39	3.9k 1.9×	467 0.3×	879 0.8×	918 0.8×	1.1k 1.1×	124	6.2k
Karen Piper Hanley United Kingdom	44	1.1k 0.5×	919 0.6×	2.2k 1.9×	640 0.6×	513 0.5×	119	5.7k
David J. Shealy United States	28	2.3k 1.1×	1.3k 0.9×	1.1k 1.0×	655 0.6×	964 1.0×	40	5.1k
Kiichiro Tsuchiya Japan	35	1.0k 0.5×	911 0.6×	1.7k 1.5×	1.2k 1.1×	446 0.5×	150	4.2k

Countries citing papers authored by Manon E. Wildenberg

Since Specialization

Citations

This map shows the geographic impact of Manon E. Wildenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manon E. Wildenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manon E. Wildenberg more than expected).

Fields of papers citing papers by Manon E. Wildenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manon E. Wildenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manon E. Wildenberg. The network helps show where Manon E. Wildenberg may publish in the future.

Co-authorship network of co-authors of Manon E. Wildenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Manon E. Wildenberg. A scholar is included among the top collaborators of Manon E. Wildenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manon E. Wildenberg. Manon E. Wildenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verseijden, Caroline, Jan Verhoeff, Manon E. Wildenberg, et al.. (2025). Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis. Inflammatory Bowel Diseases. 32(2). 290–302.

Verhoeff, Jan, Geert D’Haens, Joep Grootjans, et al.. (2023). Tu1255 FIBROBLAST ACTIVATION PROTEIN (FAP) IS STRONGLY EXPRESSED IN INTESTINAL FIBROSIS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology. 164(6). S–1009.

Roest, Manon van, Jan Verhoeff, Joep Grootjans, et al.. (2023). P110 activation protein is strongly expressed in intestinal fibrosis in inflammatory bowel disease patients. Journal of Crohn s and Colitis. 17(Supplement_1). i273–i276. 1 indexed citations

Verhoeff, Jan, Andrew Y. F. Li Yim, V Joustra, et al.. (2022). A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease. Cells. 11(18). 2846–2846. 4 indexed citations

Joustra, V, Andrew Y. F. Li Yim, Jessica R. de Bruyn, et al.. (2022). Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn’s Disease Patients. International Journal of Molecular Sciences. 23(18). 10467–10467. 4 indexed citations

Giugliano, Francesca Paola, et al.. (2021). Thiopurines correct the effects of autophagy impairment on intestinal healing – a potential role for ARHGAP18/RhoA. Disease Models & Mechanisms. 14(4). 8 indexed citations

Wildenberg, Manon E., Gerrit K. Hooijer, Monique M.A. Verstegen, et al.. (2020). Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease. SHILAP Revista de lepidopterología. 3. 100054–100054. 12 indexed citations

Koelink, Pim J., Felicia M. Bloemendaal, Bofeng Li, et al.. (2019). Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut. 69(6). 1053–1063. 164 indexed citations

Wildenberg, Manon E., et al.. (2019). Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids. Journal of Visualized Experiments. 1 indexed citations

10.

Wildenberg, Manon E., et al.. (2019). Recapitulating Suckling-to-Weaning Transition In Vitro using Fetal Intestinal Organoids. Journal of Visualized Experiments. 7 indexed citations

11.

Westendorp, B. Florien, Jacqueline L.M. Vermeulen, Sander Meisner, et al.. (2019). Colonic CD90+ Crypt Fibroblasts Secrete Semaphorins to Support Epithelial Growth. Cell Reports. 26(13). 3698–3708.e5. 73 indexed citations

12.

Jeude, Jooske F. van Lidth de, Bartolomeus J. Meijer, Wouter L. Smit, et al.. (2018). Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation. Cancer Research. 78(21). 6098–6106. 13 indexed citations

13.

Stevens, Toer, et al.. (2018). Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy. Alimentary Pharmacology & Therapeutics. 48(11-12). 1213–1231. 33 indexed citations

14.

Hansen, Ivo S., Lisette Krabbendam, Jochem H. Bernink, et al.. (2018). FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming. Nature Communications. 9(1). 863–863. 44 indexed citations

15.

Yim, Andrew Y. F. Li, Jessica R. de Bruyn, Catriona Sharp, et al.. (2018). A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn’s disease patients. PLoS ONE. 13(12). e0209656–e0209656. 14 indexed citations

16.

Bloemendaal, Felicia M., Alon D. Levin, Manon E. Wildenberg, et al.. (2017). Anti–Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis. Gastroenterology. 153(5). 1351–1362.e4. 27 indexed citations

17.

Levin, Alon D., Manon E. Wildenberg, & Gijs R. van den Brink. (2016). Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 10(8). 989–997. 257 indexed citations

18.

Strisciuglio, Caterina, Marjolijn Duijvestein, Auke P. Verhaar, et al.. (2012). Impaired autophagy leads to abnormal dendritic cell–epithelial cell interactions. Journal of Crohn s and Colitis. 7(7). 534–541. 54 indexed citations

19.

Dihal, Ashwin A., Carina L. Bos, Philip W. Voorneveld, et al.. (2011). 5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer. Gut. 61(12). 1708–1715. 27 indexed citations

20.

Duijvestein, Marjolijn, Ilse Molendijk, Helene Roelofs, et al.. (2011). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 13(9). 1066–1073. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact